Chatham Capital Group’s West Pharmaceutical WST Stock Holding History

Chatham Capital Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-508	Closed	-$209K	–	184
2022 Q1	$209K	Sell	508 -540	-52%	-$222K	0.04%	175
2021 Q4	$492K	Sell	1,048 -157	-13%	-$73.7K	0.09%	148
2021 Q3	$512K	Hold	1,205	–	–	0.1%	144
2021 Q2	$433K	Hold	1,205	–	–	0.08%	145
2021 Q1	$340K	Hold	1,205	–	–	0.07%	154
2020 Q4	$341K	Hold	1,205	–	–	0.08%	141
2020 Q3	$331K	Hold	1,205	–	–	0.08%	132
2020 Q2	$274K	Buy	+1,205	New	+$274K	0.07%	141
2020 Q1	–	Sell	-12,931	Closed	-$1.94M	–	169
2019 Q4	$1.94M	Sell	12,931 -225	-2%	-$33.8K	0.48%	56
2019 Q3	$1.87M	Sell	13,156 -135	-1%	-$19.1K	0.48%	57
2019 Q2	$1.66M	Sell	13,291 -223	-2%	-$27.9K	0.42%	65
2019 Q1	$1.49M	Sell	13,514 -4,613	-25%	-$508K	0.38%	74
2018 Q4	$1.78M	Buy	18,127 +1,762	+11%	+$173K	0.49%	52
2018 Q3	$2.02M	Hold	16,365	–	–	0.51%	44
2018 Q2	$1.63M	Buy	16,365 +350	+2%	+$34.8K	0.43%	48
2018 Q1	$1.41M	Sell	16,015 -1,435	-8%	-$127K	0.38%	51
2017 Q4	$1.72M	Buy	17,450 +150	+0.9%	+$14.8K	0.47%	48
2017 Q3	$1.67M	Hold	17,300	–	–	0.47%	47
2017 Q2	$1.64M	Buy	17,300 +1,245	+8%	+$118K	0.45%	47
2017 Q1	$1.31M	Sell	16,055 -1,245	-7%	-$102K	0.37%	58
2016 Q4	$1.47M	Buy	17,300 +3,200	+23%	+$272K	0.43%	54
2016 Q3	$1.05M	Hold	14,100	–	–	0.33%	63
2016 Q2	$1.07M	Sell	14,100 -7,450	-35%	-$565K	0.33%	59
2016 Q1	$1.49M	Hold	21,550	–	–	0.47%	46
2015 Q4	$1.3M	Hold	21,550	–	–	0.42%	52
2015 Q3	$1.17M	Sell	21,550 -300	-1%	-$16.2K	0.39%	49
2015 Q2	$1.27M	Buy	21,850 +100	+0.5%	+$5.81K	0.36%	57
2015 Q1	$1.31M	Buy	21,750 +650	+3%	+$39.1K	0.38%	53
2014 Q4	$1.12M	Hold	21,100	–	–	0.34%	58
2014 Q3	$944K	Buy	21,100 +200	+1%	+$8.95K	0.29%	70
2014 Q2	$882K	Hold	20,900	–	–	0.35%	60
2014 Q1	$921K	Sell	20,900 -4,650	-18%	-$205K	0.38%	56
2013 Q4	$1.25M	Hold	25,550	–	–	0.52%	45
2013 Q3	$1.05M	Hold	25,550	–	–	0.48%	46
2013 Q2	$898K	Buy	+25,550	New	+$898K	0.44%	48